23 results
Thumbnail

D2.432 - Therapeutic Efficacy of Platelet-Rich Plasma in Androgenic Alopecia: A Meta-Analysis of Single Versus Double-Blinded Randomized Controlled Trials

Thumbnail

D2.423 - Changes in the expression of regulatory receptors on CD8+ T cytotoxic lymphocytes as a marker of the risk of developing a post COVID-19 condition in patients after a severe course of COVID-19

Thumbnail

D2.427 - Inhibition of the IL-17 pathway in the treatment of systemic vasculitis: molecular biology and case review

Thumbnail

D2.429 - Virus-Specific Regulatory T-Cell Dysregulation in Post-COVID-19 and EBV-Associated Vasculitis

Thumbnail

D2.430 - Automated 24-Hour Quantification of Scratching Behavior Reveals Distinct Physiological and Allergic Pruritus Signatures in Mice

Thumbnail

D3.70 - Structural and immunological insights into arginine kinases from house dust mites and related arthropods

Thumbnail

D3.63 - Molecular Evidence of PR-10 in Cannabis Allergy

Thumbnail

D3.64 - Alcohol-Soluble Wheat Proteins as the Likely Allergenic Trigger in a Patient With Reaction to Gin

Thumbnail

D3.66 - When dermatitis follows the menstrual cycle: two cases of endogenous progestogen hypersensitivity

Thumbnail

D3.67 - Retrospective Evaluation of IgE Panel Utility in Allergy Diagnostics: Insights from Baghdad, Iraq

Thumbnail

D3.71 - A research tool for development of in-house specific IgE immunoassays - comparison between different methods

Thumbnail

D3.73 - Clinical Performance of Hycor NOVEOS–Based Specific IgE Measurements for the Screening of Respiratory Allergies

Thumbnail

D3.74 - Age-related characteristics of children's sensitisation to timothy grass according to component diagnostics

Thumbnail

D3.76 - Open-Label Clinical Trial To Evaluate The Effect Of Intranasal Olopatadine/Mometasone And Azelastine/Mometasone On Histamine Reactivity In Skin Prick Tests

Thumbnail

D3.77 - Tattoo Ink Allergy? Diagnostic Challenges in Cutaneous Reactions to Tattoo Ink Containing Metals

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project